Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
9/6/2024 | $72.00 | Buy → Hold | TD Cowen |
1/10/2024 | $63.00 | Overweight | KeyBanc Capital Markets |
12/2/2022 | $65.00 | Buy | BofA Securities |
3/18/2022 | $65.00 | Buy | Stifel |
3/4/2022 | Neutral → Buy | DA Davidson | |
2/1/2022 | $50.00 → $55.00 | Overweight | Keybanc |
10/29/2021 | $47.00 → $51.00 | Outperform | Credit Suisse |
10/26/2021 | $45.00 → $50.00 | Overweight | Keybanc |
SC 13G/A - KBR, INC. (0001357615) (Subject)
SC 13G/A - KBR, INC. (0001357615) (Subject)
SC 13G/A - KBR, INC. (0001357615) (Subject)
4 - KBR, INC. (0001357615) (Issuer)
4 - KBR, INC. (0001357615) (Issuer)
4 - KBR, INC. (0001357615) (Issuer)
TD Cowen downgraded KBR from Buy to Hold and set a new price target of $72.00
KeyBanc Capital Markets resumed coverage of KBR with a rating of Overweight and set a new price target of $63.00
BofA Securities resumed coverage of KBR with a rating of Buy and set a new price target of $65.00
10-Q - KBR, INC. (0001357615) (Filer)
8-K - KBR, INC. (0001357615) (Filer)
DEFA14A - KBR, INC. (0001357615) (Filer)
HOUSTON, May 07, 2025 (GLOBE NEWSWIRE) -- KBR (NYSE:KBR) announced today it has received NASA Super Nova Awards for 2024 Safety Excellence from the Johnson Space Center (JSC) Contractor Safety Forum on four contracts within NASA's Human Exploration Division: the Mission Systems Operations Contract (MSOC), the Integrated Mission Operations Contract (IMOC), the Human Health and Performance Contract (HHPC), and the Extravehicular Activity Space Operations Contract (ESOC) as a major subcontractor to United Technologies Collins Aerospace. This prestigious award recognizes KBR's outstanding safety performance over the past year. The NASA Super Nova Award celebrates exceptional safety and health
Delivered Strong Financial Performance, Consistent Execution on Major Projects, and New Contract Wins Over $150 million of Share Repurchases in the Quarter First Quarter Fiscal 2025 Highlights(All comparisons against the first quarter fiscal 2024 unless noted.) Revenues of $2.1 billion, up 13%Net income attributable to KBR of $116 million; Adjusted EBITDA2 of $243 million, up 17% with an Adjusted EBITDA2 margin of 11.8%Diluted EPS of $0.88; Adjusted EPS2 of $0.98, up 27%Bookings and options1 of $1.4 billion with 1.0x book-to-bill1 (1.1x TTM book-to-bill1) Fiscal Year 2025 Guidance Reaffirming previously provided outlook HOUSTON, May 06, 2025 (GLOBE NEWSWIRE) -- KBR, Inc. (NYSE:KBR)
Highlights Binding strategic alliance with KBR (NYSE: KBR), a world-leading engineering group and global technology licensor set to supercharge Hazer's commercialisation strategyHazer is KBR's exclusive partner for marketing and licensing of methane pyrolysis technologyClear revenue visibility targeting multiple license deals within 6 years, materially derisking Hazer's businessplan Capital-lite licensing model maintained; KBR A$3million work program contribution preserves Hazer's robust funding positionStrengthens Hazer's market penetration into high-growth market segments of ammonia and methanol, and regions including North America and Middle EastCEO Glenn Corrie and other members of the
HOUSTON, Feb. 24, 2025 /PRNewswire/ -- KBR, Inc. (NYSE:KBR) announced today that the independent directors of the KBR Board have unanimously elected Lt. General Wendy M. Masiello as Lead Independent Director, effective as of KBR's 2025 annual meeting of stockholders to be held in May 2025. Lt. General Masiello has served on KBR's Board of Directors since August 2017, including as the current Chair of the Cybersecurity Committee and a member of the Compensation Committee and Sustainability & Corporate Responsibility Committee. A three-star General of the U.S. Air Force, Lt. Gen
HOUSTON, Aug. 12, 2024 /PRNewswire/ -- KBR (NYSE:KBR) announced today the appointment of Nchacha E. Etta to its Board of Directors effective August 12, 2024. Nchacha E. Etta is executive vice president and chief financial officer of Omnicell, Inc., a multinational healthcare technology company. His breadth of finance and accounting experience stems from leading and working in global finance organizations across the healthcare and consumer products industries for more than 20 years. Prior to joining Omnicell, Mr. Etta served as senior vice president and chief financial officer
HOUSTON, Dec. 18, 2023 /PRNewswire/ -- KBR (NYSE:KBR) is pleased to join forces with The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) on an important contract to support neuroscience research for service members. This new award will specifically focus on those affected by traumatic brain injuries. Research will be done in collaboration with the Uniformed Services University (the nation's only federal health sciences university), and the University of California San Francisco (UCSF). Under the terms of the Service Personnel Advancing Research in Ch
4 - KBR, INC. (0001357615) (Issuer)
Delivered Strong Financial Performance, Consistent Execution on Major Projects, and New Contract Wins Over $150 million of Share Repurchases in the Quarter First Quarter Fiscal 2025 Highlights(All comparisons against the first quarter fiscal 2024 unless noted.) Revenues of $2.1 billion, up 13%Net income attributable to KBR of $116 million; Adjusted EBITDA2 of $243 million, up 17% with an Adjusted EBITDA2 margin of 11.8%Diluted EPS of $0.88; Adjusted EPS2 of $0.98, up 27%Bookings and options1 of $1.4 billion with 1.0x book-to-bill1 (1.1x TTM book-to-bill1) Fiscal Year 2025 Guidance Reaffirming previously provided outlook HOUSTON, May 06, 2025 (GLOBE NEWSWIRE) -- KBR, Inc. (NYSE:KBR)
HOUSTON, April 03, 2025 (GLOBE NEWSWIRE) -- KBR (NYSE:KBR) announced today that it will host a conference call to discuss its first quarter financial results on Tuesday, May 6, 2025, at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). The company plans to issue its first quarter 2025 earnings release and earnings presentation in advance of the call. Both will be available on KBR's website. The conference call will be webcast simultaneously through the Investor Relations section of KBR's website at investors.kbr.com. A replay of the webcast will be available after the call on our website or by telephone at +1.866.813.9403, passcode: 502816. About KBR We deliver science, technology
Delivered Strong Financial Performance with Solid Bookings Momentum Issues Fiscal Year 2025 Guidance for Revenues, Adj. EBITDA, Adj. EPS, and Operating Cash Flows Fourth Quarter 2024 Highlights(All comparisons versus prior year period unless noted.) Revenues of $2.1 billion, up 23% (15% organic)Net income attributable to KBR of $76 million; Adjusted EBITDA2 of $228 million, up 21% with an Adjusted EBITDA2 margin of 10.7%Diluted EPS of $0.57; Adjusted EPS2 of $0.91, up 32%Bookings and options1 of $2.0 billion with 1.0x book-to-bill1Fiscal Year 2024 Highlights(All comparisons versus prior year period unless noted.) Revenues of $7.7 billion, up 11% (9% organic)Net income attributable to KBR of